Skip to main content
Premium Trial:

Request an Annual Quote

Laurie Huard, Karol Ford, Tania Obranovich, and John Alsobrook

Clinical Genomics has appointed Laurie Huard as chief operating officer, Karol Ford as vice president of sales and marketing, Tania Obranovich as vice president of intellectual property, legal affairs and compliance, and John Alsobrook as clinical laboratory director.

Huard comes to Clinical Genomics from Helomics where she served as vice president of operations. She has also served as a director for a large integrated hospital laboratory, and has operated a laboratory informatics consulting practice for more than 10 years. Ford comes to Clinical Genomics from Progenity, where she has held various positions. Obranovich currently practices law as a patent attorney. She has spent the last ten years as a partner at a top tier Australian intellectual property firm. Alsobrook comes to Clinical Genomics from DermTech where he served as chief science officer. He also served as CEO, director of discovery, and vice president of clinical laboratory operations at Exagen Diagnostics.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.